The incidence of early-onset colorectal cancer has increased by nearly 50 percent in the last 30 years. A University of Colorado Cancer Center study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago aimed to iden ...
A new colorectal cancer vaccine showed positive results in phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events ...
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteri ...